局限性前列腺癌治疗后患者报告结局的种族差异:CEASAR研究结果
CEASAR前瞻性人群观察研究纳入2011-2012年诊断为局限性前列腺癌的3708例男性,用EPIC量表在基线和入组后6、12个月评估功能。与主动监测相比,根治性前列腺切除术后尿失禁评分下降幅度非裔美国男性大于白人男性(校正差中差8.4分,95%CI 2.0-14.8;p=0.01),但烦恼评分无差异,性功能、肠道、排尿刺激和激素领域未见临床显著的种族差异。
要点
- 根治性前列腺切除术后1年尿失禁在非裔美国男性可能比白人男性更重,但总体差异不大。
- 治疗选择和基线功能解释治疗后功能变异的比例远大于种族/族裔。
- 性功能、肠道、排尿刺激和激素领域未见临床显著的种族差异,烦恼评分无差异。
核心结论
- 根治性前列腺切除术后1年尿失禁在非裔美国男性可能比白人男性更重,但总体差异不大。
- 治疗选择和基线功能解释治疗后功能变异的比例远大于种族/族裔。
研究设计与样本
- CEASAR研究为前瞻性、基于人群的观察性研究,纳入2011-2012年诊断为局限性前列腺癌的3708例男性。
- 使用26条目的扩展前列腺指数复合量表(EPIC)在基线和入组后6、12个月测量患者报告疾病特异性功能。
- 采用风险校正的广义估计方程按种族比较功能的平均治疗差异。
主要发现
- 与主动监测相比,根治性前列腺切除术后所有种族/族裔组的尿失禁评分均大幅下降,非裔美国男性报告的差异大于白人男性(校正差中差8.4分,95%CI 2.0-14.8;p=0.01)。
- 烦恼评分未见差异,归因于种族/族裔的变异解释比例相对于主要治疗和基线功能较小。
- 性功能、肠道、排尿刺激或激素领域未见临床显著的种族变异。
局限性
- 局限性包括缺乏EPIC量表临床意义的公认阈值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Relatively little is known about the relationship between race/ethnicity and patient-reported outcomes after contemporary treatments for localized prostate cancer. OBJECTIVE: To test the hypothesis that treatment-related changes in urinary, bowel, sexual, and hormonal function vary by race/ethnicity. DESIGN, SETTING, AND PARTICIPANTS: The Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) study is a prospective, population-based, observational study that enrolled 3708 men diagnosed with localized prostate cancer in 2011-2012. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Patient-reported disease-specific function was measured using the 26-item Expanded Prostate Index Composite (EPIC) at baseline and 6 and 12 mo after enrollment. Mean treatment differences in function were compared by race using risk-adjusted generalized estimating equations. RESULTS AND LIMITATIONS: While all race/ethnic groups reported considerable declines in scores for urinary incontinence after radical prostatectomy (RP) when compared to active surveillance, African-American men reported a greater difference than white men did (adjusted difference-in-differences 8.4 points, 95% confidence interval 2.0-14.8; p=0.01). No difference in bother scores was noted and the overall proportion of explained variation attributable to race/ethnicity was relatively small in comparison to primary treatment and baseline function. No clinically significant racial variation was noted for the sexual, bowel, irritative voiding, or hormone domains. Limitations include the lack of well-established thresholds for clinical significance using the EPIC instrument. CONCLUSION: While these data demonstrate that incontinence at 1 yr after RP may be worse for African-American compared to white men, the difference appears to be modest overall. Treatment selection and baseline function explain a much greater proportion of the variation in function after treatment. PATIENT SUMMARY: We observed that the effect of treatment for prostate cancer on patient-reported function did not vary dramatically by race/ethnicity. Compared to white men, African-American men experienced a somewhat more pronounced decline in urinary continence after radical prostatectomy, but the corresponding changes in bother scores were not significantly different between the two groups.
引用
- Tyson MD, Alvarez J, Koyama T, et al. Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study. Eur Urol. 2016. PMID: 27816300. doi:10.1016/j.eururo.2016.10.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。